ArticleHaematologica2022

Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis.

Yago Nieto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.